Related Experiment Video
Updated: Aug 25, 2025

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Role of fluid-phase complement system regulation in the development of hepatitis C virus-associated
Sara T Ibrahim1, Marwa R Abdelhamid2, Neveen Lewis3
1Department of Internal Medicine and Nephrology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Insights
Low C4BP levels are linked to glomerulonephritis (GN) in hepatitis C virus (HCV) patients. A specific CFH gene variant (rs800292) appears protective against HCV-associated GN.
Area of Science:
- Nephrology
- Immunology
- Virology
Background:
- Hepatitis C virus (HCV) infection can lead to glomerulonephritis (GN), a kidney disease.
- The exact mechanisms driving HCV-associated GN development in some patients remain unclear.
- Complement system dysregulation is implicated in various kidney diseases.
Purpose of the Study:
- To investigate the role of soluble complement regulators in the pathogenesis of HCV-associated GN.
- To identify potential biomarkers for predicting GN development in HCV-infected individuals.
Main Methods:
- A case-control study involving 78 participants: 26 with HCV-associated GN, 26 with HCV without GN, and 26 healthy controls.
- Serum levels of complement regulators, including C4BP, were measured using ELISA.
- Analysis of complement single nucleotide polymorphisms (SNPs) in C3 and CFH genes using real-time PCR.
Main Results:
- Significantly lower serum levels of C4BP were observed in patients with HCV-associated GN compared to controls (p=0.007).
- The minor allele (A) of the CFH gene polymorphism rs800292 was less frequent in patients with HCV-associated GN (27%) than in controls (46%) (p=0.04).
Conclusions:
- Reduced C4BP levels are associated with the development of GN in HCV-infected patients.
- The rs800292 SNP in the CFH gene may confer a protective effect against HCV-associated GN.
Objectives:
It is not known why only some hepatitis C virus (HCV) infected patients develop glomerulonephritis (GN). Therefore, we investigated the role of soluble complement regulators in the development of HCV associated GN.
Methods:
Patients with HCV associated GN who were admitted to our nephrology unit between July 2016 and July 2018 were recruited to the study (group 1). Two other age and sex matched groups were studied as control groups: patients with HCV without GN (group 2) and healthy HCV negative volunteers (group 3). There were 26 participants in each of the three groups at the end of the recruitment period. An assay of serum fluid-phase complement regulators was performed using enzyme linked immunosorbent assay technique. Three complement single nucleotide polymorphisms (SNPs) were analyzed using real time polymerase chain reaction (Taqman; thermo fisher scientific): rs2230199 and rs1047286 for complement 3 (C3) and rs800292 for complement factor H (CFH).
Results:
Serum levels of complement 4 binding protein (C4BP) were significantly lower in group 1 (median 70 ng/ml) than in groups 2 (median 88.8 ng/ml) and 3 (median 82.8 ng/ml) with p value of 0.007. The minor allele (allele A) of rs800292 for CFH was significantly higher in group 2 and group 3 (G 54% and A 46%) than in group 1 (G 73% and A 27%), p = 0.04.
Conclusions:
Low C4BP levels are associated with GN in HCV infected patients. In addition, rs800292 SNP in CFH protects against GN in patients with HCV.
Related Concept Videos
Complement System
Nephrotic Syndrome I : Introduction
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Acute Kidney Injury II: Pathophysiology
Glomerular Filtration Rate and its Regulation
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
Nephrotic Syndrome II : Assessment and Medical Management

